Abstract
A 200-mg amount of bacampicillin showed a significantly higher relative extent of bioavailability than did a 250-mg amount of talampicillin, possibly due to their different stability in the digestive juices.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Jones K. H. Bioavailability of talampicillin. Br Med J. 1977 Jul 23;2(6081):232–233. doi: 10.1136/bmj.2.6081.232-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones K. H., Langley P. F., Lees L. J. Bioavailability and metabolism of talampicillin. Chemotherapy. 1978;24(4):217–226. doi: 10.1159/000237784. [DOI] [PubMed] [Google Scholar]
- Magni L., Sjövall J., Syvälahti E. Comparative clinical pharmacology of bacampicillin and high oral doses of ampicillin. Infection. 1978;6(6):283–289. doi: 10.1007/BF01641988. [DOI] [PubMed] [Google Scholar]
- Sjövall J., Magni L., Bergan T. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother. 1978 Jan;13(1):90–96. doi: 10.1128/aac.13.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verbist L. Triple crossover study on absorption and excretion of ampicillin, talampicillin, and amoxycillin. Antimicrob Agents Chemother. 1976 Jul;10(1):173–175. doi: 10.1128/aac.10.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]